Protective effect of a mixture of aloe vera and silybum marianum against carbon tetrachloride-induced acute hepatotoxicity and liver fibrosis

Journal of Pharmacological Sciences

Volumn 109, Issue 1, 2009, Pages 119-127

  Kim, Sung Hwa ^a   Cheon, Ho Jun ^a   Yun, Nari ^a   Oh, Sun Tack ^b   Shin, Eunju ^b   Shim, Kyu Suk ^b   Lee, Sun Mee ^a  

^a Sungkyunkwan University   (South Korea)

^b Univera Inc   (South Korea)

Author keywords

Aloe vera silybum marianum mixture (ACTIValoe N 931 complex); Anti inflammation; Anti oxidant; Carbon tetrachloride; Fibrosis

Indexed keywords

ACTIVALOE N 931; ALOE VERA EXTRACT PLUS SILYBUM MARIANUM EXTRACT; AMINOTRANSFERASE; CARBON TETRACHLORIDE; CYCLOOXYGENASE 2; GROWTH HORMONE; HYDROXYPROLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIVER PROTECTIVE AGENT; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE TOXICITY; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COX 2 GENE; GENE; INOS GENE; LIPID PEROXIDATION; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; TIMP 1 GENE; TNF ALPHA GENE;

EID: 58649093753     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08189FP     Document Type: Article

References (37)

1. McCay PB, Lai EK, Poyer JL, DuBose CM, Janzen EG. Oxygen- and carbon-centered free radical formation during carbon tetrachloride metabolism. Observation of lipid radicals in vivo and in vitro. J Biol Chem. 1984;259:2135-2143.
2. Gagandeep S, Rajvanshi P, Sokhi RP, Slehria S, Palestro CJ, Bhargava KK, et al. Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride- induced cirrhosis. J Pathol. 2000;191:78-85.
3. Reynolds T, Dweck AC. Aloe vera leaf gel: a review update. J Ethnopharmacol. 1999;68:3-37.
4. Chandan BK, Saxena AK, Shukla S, Sharma N, Gupta DK, Suri KA, et al. Hepatoprotective potential of Aloe barbadensis Mill. against carbon tetrachloride induced hepatotoxicity. J Ethnopharmacol. 2007;111:560-566.
5. Lim BO, Seong NS, Choue RW, Kim JD, Lee HY, Kim SY, et al. Efficacy of dietary aloe vera supplementation on hepatic cholesterol and oxidative status in aged rats. J Nutr Sci Vitaminol (Tokyo). 2003;49:292-296.
6. Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, Yanardag R, et al. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull. 2004;27:694-698.
7. Post-White J, Ladas EJ, Kelly KM. Advances in the use of milk thistle (Silybum marianum). Integr Cancer Ther. 2007;6:104-109.
8. Vaknin Y, Hadas R, Schafferman D, Murkhovsky L, Bashan N. The potential of milk thistle (Silybum marianum L.), an Israeli native, as a source of edible sprouts rich in antioxidants. Int J Food Sci Nutr. 2007;20:1-8.
9. Moon YJ, Cheon HJ, Lee WC, Kim HY, Oh ST, Shin EJ, et al. Protective effect of ACTIValoe®N-931 complex, a mixture of Aloe vera and Silybum marinum, on experimental acute liver injury. Biomol Ther. 2008;16:203-209.
10. Lee CH, Park SW, Kim YS, Kang SS, Kim JA, Lee SH, et al. Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. Biol Pharm Bull. 2007;30:1898-1904.
11. Oh WY, Pyo S, Lee KR, Lee BK, Shin DH, Cho SI, et al. Effect of Holotrichia diomphalia larvae on liver fibrosis and hepatotoxicity in rats. J Ethnopharmacol. 2003;87:175-180.
12. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502-522.
13. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980;106:207-212.
14. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-310.
15. Schenkman JB, Remmer H, Estabrook RW. Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol Pharmacol. 1967;3:113-123.
16. Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem. 1981;112:70-75.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
18. Ahmed S, Rahman A, Alam A, Saleem M, Athar M, Sultana S. Evaluation of the efficacy of Lawsonia alba in the alleviation of carbon tetrachloride-induced oxidative stress. J Ethnopharmacol. 2000;69:157-164.
19. Badger DA, Sauer JM, Hoglen NC, Jolley CS, Sipes IG. The role of inflammatory cells and cytochrome P450 in the potentiation of CCl4-induced liver injury by a single dose of retinol. Toxicol Appl Pharmacol. 1996;141:507-519.
20. Hishinuma I, Nagakawa J, Hirota K, Miyamoto K, Tsukidate K, Yamanaka T, et al. Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology. 1990;12:1187-1191.
21. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol. 1995;154:1307-1316.
22. Morio LA, Chiu H, Sprowles KA, Zhou P, Heck DE, Gordon MK, et al. Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol. 2001;172:44-51.
23. Zhou Z, Wang L, Song Z, Lambert JC, McClain CJ, Kang YJ. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. Am J Pathol. 2003;163:1137- 1146.
24. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992;70: 431-442.
25. Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem Biophys Res Commun. 1999;254:764-767.
26. Planagumà A, Clària J, Miquel R, López-Parra M, Titos E, Masferrer JL, et al. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving nonparenchymal cell apoptosis and PPARgamma activation. FASEB J. 2005;19:1120-1122.
27. Harries HM, Fletcher ST, Duggan CM, Baker VA. The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicol In Vitro. 2001;15:399-405.
28. Senoo H, Imai K, Matano Y, Sato M. Molecular mechanisms in the reversible regulation of morphology, proliferation and collagen metabolism in hepatic stellate cells by the three- dimensional structure of the extracellular matrix. J Gastroenterol Hepatol. 1998;13:S19-S32.
29. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 2000;21:49-98.
30. Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol. 2004;44:27-42.
31. Bedossa P, Paradis V. Transforming growth factor-beta (TGF- beta): a key-role in liver fibrogenesis. J Hepatol. 1995;22:37-42.
32. Basbaum CB, Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol. 1996;8:731-738.
33. Freije JM, Díez-Itza I, Balbín M, Sánchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem. 1994;269:16766-16773.
34. Préaux AM, Mallat A, Nhieu JT, D'Ortho MP, Hembry RM, Mavier P. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions. Hepatology. 1999;30:944-950.
35. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, et al. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology. 2002;36:850-860.
36. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJ. Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci. 1995;89:75-81.
37. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987;6:1899-1904.